Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
event decrease » cement decreases (Expand Search), point decrease (Expand Search), levels decreased (Expand Search)
Showing 1,381 - 1,400 results of 36,050 for search '(( significant decrease decrease ) OR ( significant ((event decrease) OR (levels increased)) ))', query time: 0.52s Refine Results
  1. 1381
    Role of YAP/TAZ in FAT1-regulated HNSCC growth.

    Role of YAP/TAZ in FAT1-regulated HNSCC growth. by Rui Li (4631)

    Published 2025
    Save to List
    Saved in:
  2. 1382
    GO and KEGG analysis results of PA against osteosarcoma.

    GO and KEGG analysis results of PA against osteosarcoma. by Zeyu Zhan (22305085)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 1383
    FAT1 and MIB2 control tumor growth <i>in vivo.</i>

    FAT1 and MIB2 control tumor growth <i>in vivo.</i> by Rui Li (4631)

    Published 2025
    Save to List
    Saved in:
  4. 1384
    FAT1 interacts with the E3 ligase MIB2.

    FAT1 interacts with the E3 ligase MIB2. by Rui Li (4631)

    Published 2025
    Save to List
    Saved in:
  5. 1385
    Volcano plot on differential expression.

    Volcano plot on differential expression. by Bingshuo Shi (21485387)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 1386
    Receiver operating characteristic curve analyses for the prediction of hepatitis C.

    Receiver operating characteristic curve analyses for the prediction of hepatitis C. by Lu Han (151620)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 1387
    Exploring the correlation between systemic inflammation biomarkers and HCV infection (logarithm base 2).

    Exploring the correlation between systemic inflammation biomarkers and HCV infection (logarithm base 2). by Lu Han (151620)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 1388
    Threshold effect analysis of systemic inflammatory biomarkers on hepatitis C using two-piece wise linear regression.

    Threshold effect analysis of systemic inflammatory biomarkers on hepatitis C using two-piece wise linear regression. by Lu Han (151620)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 1389
    Exclusion and enrollment summary from NHANES.

    Exclusion and enrollment summary from NHANES. by Lu Han (151620)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 1390
    Demographic information and baseline population characteristics.

    Demographic information and baseline population characteristics. by Lu Han (151620)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 1391
    Stratified associations between systemic inflammation biomarkers and hepatitis C (OR 95%, <i>P</i> value, LOG base 2).

    Stratified associations between systemic inflammation biomarkers and hepatitis C (OR 95%, <i>P</i> value, LOG base 2). by Lu Han (151620)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 1392
    General addictive models demonstrate the relationship between systemic inflammatory biomarkers and anti-HCV.

    General addictive models demonstrate the relationship between systemic inflammatory biomarkers and anti-HCV. by Lu Han (151620)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 1393
    Comparison of systemic inflammation biomarkers in infected and uninfected populations.

    Comparison of systemic inflammation biomarkers in infected and uninfected populations. by Lu Han (151620)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 1394
    Logistics regression analysis for the associations between decreased kidney function (eGFR < 90 mL/min/1.73 m<sup>2</sup>) and sex-specific z-scores of anthropometric indices, weighted.

    Logistics regression analysis for the associations between decreased kidney function (eGFR < 90 mL/min/1.73 m<sup>2</sup>) and sex-specific z-scores of anthropometric indices, weig... by Xinyun Chen (6655703)

    Published 2025
    Save to List
    Saved in:
  15. 1395
    Effects of bevacizumab addition on VEGF-A concentrations <i>in vitro</i>.

    Effects of bevacizumab addition on VEGF-A concentrations <i>in vitro</i>. by Masashi Okawa (8951294)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  16. 1396
    The characteristics and clinical features of 12 patients.

    The characteristics and clinical features of 12 patients. by Masashi Okawa (8951294)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  17. 1397
    Effect of adding rhVEGF-A (-121 or -165) on the concentrations of VEGF-A121 and VEGF-A165 in plasma samples.

    Effect of adding rhVEGF-A (-121 or -165) on the concentrations of VEGF-A121 and VEGF-A165 in plasma samples. by Masashi Okawa (8951294)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 1398
    Effect of the VEGF-A–bevacizumab complex removal using immunoprecipitation on the concentrations of VEGF-A121, VEGF-A165, and VEGF-A.

    Effect of the VEGF-A–bevacizumab complex removal using immunoprecipitation on the concentrations of VEGF-A121, VEGF-A165, and VEGF-A. by Masashi Okawa (8951294)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  19. 1399
    Equation of the equilibrium dissociation constant of the antigen-antibody reaction.

    Equation of the equilibrium dissociation constant of the antigen-antibody reaction. by Masashi Okawa (8951294)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 1400
    The original data for the figures.

    The original data for the figures. by Masashi Okawa (8951294)

    Published 2024
    Subjects:
    Save to List
    Saved in:

Search Tools: